Among the tasks used, DDK proved to be a promising variable for discriminating patients with PD from patients with SCA3 although it was impossible to distinguish SCA3 from control subjects at the DDK task in our study; only the PD patients differed from controls. The gene discussed is ATXN3; the disease is Parkinson disease.